Cargando…
“Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
European Respiratory Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832399/ http://dx.doi.org/10.1183/09031936.50090311 |
_version_ | 1782427252248543232 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4832399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-48323992016-07-27 “Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27. Eur Respir J Erratum European Respiratory Society 2012-09 /pmc/articles/PMC4832399/ http://dx.doi.org/10.1183/09031936.50090311 Text en ©ERS 2012 |
spellingShingle | Erratum “Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27. |
title | “Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27. |
title_full | “Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27. |
title_fullStr | “Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27. |
title_full_unstemmed | “Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27. |
title_short | “Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27. |
title_sort | “moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of copd: maestral results”. robert wilson, antonio anzueto, marc miravitlles, pierre arvis, jeff alder, daniel haverstock, mila trajanovic and sanjay sethi. eur respir j 2012; 40: 17–27. |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832399/ http://dx.doi.org/10.1183/09031936.50090311 |